vivax parasites
vivax CHMI model
vivax accounts
Multiple Lifecycle Stages of Plasmodium vivax malaria Plasmodium vivax
widespread malaria
vaccine intervention
vaccine development process
revised Malaria Vaccine Technology Roadmap
Development of Effective Vaccines
vivax long-term culture system
early indication of vaccine efficacy
successful vaccine candidates
current bottleneck
existing vaccines
better selection of effective vaccines
new vaccines
clinical cases
lack of assays
significant proportion of human malaria cases
clinical development pipeline
safe controlled human malaria infection
transmission-stages
humans
current leading antigens
critical bottlenecks
order
novel antigens
falciparum
early-phase clinical testing
lack of easy access
novel transgenic parasites
parasite RNASeq
risk curve
protective blood-stage immunity
advantage of recent advances
immuno-screening
efforts
Latin America
use
interventions
Oceania
people
MultiViVax proposal
time
severity of
inability
Europe
global health need
Asia
Objectives
years